-
Altimmune Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
-
Pre-Open Stock Movers 07/13: (BFYT) (ALT) (TSLA) Higher; (CLSN) Lower (more...)
-
Companies with NDRs 4/01
-
Roth Capital Starts Altimmune (ALT) at Buy
-
Roth Capital Starts Altimmune (ALT) at Buy
-
Altimmune Announces Closing of $14 Million Registered Direct Offering
-
Altimmune (ALT) Announces 4.36M Unit Registered Direct Offering for Expected Gross Proceeds at Approx. $14M
-
Altimmune Announces $14 million Registered Direct Offering
-
Pre-Open Movers 10/08: (PBR) (TTPH) (ARNC) Higher; (ALT) (GLUU) (IRBT) Lower (more...)
-
Altimmune (ALT) Announces $25M Direct Offering via Roth Capital
-
Altimmune Announces $25 million Registered Direct Offering
-
Altimmune Closes on $16.9 Million in Funding
-
Altimmune (ALT) Prices $12 Million Underwritten Public Offering of Common Units and Pre-funded Units
-
Altimmune Announces Pricing of $12 Million Underwritten Public Offering
-
Altimmune (ALT) Sells ~287K Shares at $17.02 in Direct Offering
-
Altimmune Announces $4.9 million Registered Direct Offering of Common Stock

